Skip to content

Development of a Novel Anti-caries Chewing Gum

Development of a Novel Anti-caries Chewing Gum

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05946473
Enrollment
30
Registered
2023-07-14
Start date
2023-07-31
Completion date
2024-04-30
Last updated
2023-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Dental Plaque, Periodontal Disease

Brief summary

This research study is designed to evaluate the chewing gum's ability to modulate the oral microbiome in human participants, in addition to its safety.

Detailed description

The goal of this project is to develop a pre-biotic chewing gum that is designed to promote a healthy oral microbiome. The gum will contain compounds that will: a) be unable to be converted to acids; b) target the cariogenic S. mutans population; c) promote the stability of a healthy environment by modulating plaque pH via base-generating compounds; d) promote tooth remineralization by increasing saliva flow and by addition of calcium phosphate.

Interventions

DIETARY_SUPPLEMENTGum base containing xylitol and essencial oils

Participants will be asked to chew 2 pieces of chewing gum containing additives for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

DIETARY_SUPPLEMENTGum base with no additives

Participants will be asked to chew 2 pieces of pure gum base for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* In good general health, no relevant medical history * No dental treatment in the previous 3 months * Willing to participate and give written informed consent

Exclusion criteria

* Patients undergoing fixed or removable orthodontic treatment * Patients using removable prosthesis * History of head and neck radiation therapy * History of adverse reaction or allergies to xylitol or other additives * Antibiotics use in the last four weeks * Patients with any systemic diseases * Xerostomia (also medication-induced) * Smokers * Currently using any mouth rinse * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Change in target species of the oral microbiome28 daysTotal microbiome analyses will be performed at the beginning and end of the study (4 weeks) to assess total cultivable flora, levels of S. mutans, S. salivarius, and P. gingivalis in addition to using qRT-PCR from plaque and saliva samples

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026